Evidence map›Paper›PMID 11207652›Full record

ArticleClinical and experimental immunology2001

Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85.

M T Valle, A M Megiovanni, A Merlo, G Li Pira, L Bottone, G Angelini, L Bracci, L Lozzi, K Huygen, F Manca

Abstract read
In one paragraph

Article in Clinical and experimental immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Antigen 85B ofVaccines · 2026
    Review
  2. Article
  3. F18 Promiscuous Epitope of Acr1 Protein ofProtein and peptide letters · 2025
    Article
  4. Article
  5. Latent tuberculosis testing through the ages: the search for a sleeping killer.American journal of physiology. Lung cellular and molecular physiology · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M T ValleImmunology Laboratory, San Martino Hospital and Unit of Retroviral Immunology, Advanced Biotechnology Centre, Genoa, Italy.
A M Megiovanni
A Merlo
G Li Pira
L Bottone
G Angelini
L Bracci
L Lozzi
K Huygen
F Manca

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphoproliferation of healthy donors was tested against mycobacterial antigens (PPD, Ag85, Ag85 peptides). All PPD responders recognized the secretory antigen Ag85 and the peptide specificity for Ag85B was defined. Peptide 91-108 was recognized by 85% of donors. In addition, all CD4 T cell lines generated from 12 donors against PPD or Ag85 responded to 91-108. When this peptide was used to generate T cell lines, the cells responded also to tuberculins from atypical mycobacterial species. Thus the cross-reactive peptide behaved as quasi-universal. The analysis of TCR-BV gene usage by cell lines showed that most Ag85-specific T cells correspond to 91-108-specific clonotypes. Intracytoplasmic staining of cell lines after phorbol myristate acetate stimulation resulted in dominance of interferon-gamma (IFN-gamma)-IL-4 double-positive cells, whereas antigen stimulation resulted in production of IFN-gamma only. The data show that peptide 91-108 is the major focus of the CD4 response to mycobacterial antigens in peripheral blood mononuclear cells and in T cell lines from PPD responders.

Indexed as

AcyltransferasesAntigens, BacterialCD4 AntigensCD4-Positive T-LymphocytesCell DifferentiationCytotoxicity, ImmunologicEpitopes, T-LymphocyteHumansMycobacterium tuberculosisTh1 CellsAcyltransferasesantigen 85A, Mycobacterium tuberculosisAntigens, BacterialCD4 AntigensEpitopes, T-Lymphocyte

Identifiers

PMID11207652
PMCPMC1905982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.